These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 24009024)

  • 1. Emerging roles of claudins in human cancer.
    Kwon MJ
    Int J Mol Sci; 2013 Sep; 14(9):18148-80. PubMed ID: 24009024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudins and cancer stem cells.
    Turksen K
    Stem Cell Rev Rep; 2011 Nov; 7(4):797-8. PubMed ID: 21526417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Claudin Proteins in Regulating Cancer Stem Cells and Chemoresistance-Potential Implication in Disease Prognosis and Therapy.
    Gowrikumar S; Singh AB; Dhawan P
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines.
    Ogawa M; Kojima T; Someya M; Nomura K; Takasawa A; Murata M; Tanaka S; Saito T; Sawada N
    Histochem Cell Biol; 2012 Aug; 138(2):323-38. PubMed ID: 22544349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudins and cancer: Fall of the soldiers entrusted to protect the gate and keep the barrier intact.
    Singh AB; Dhawan P
    Semin Cell Dev Biol; 2015 Jun; 42():58-65. PubMed ID: 26025580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claudins: The Newly Emerging Targets in Breast Cancer.
    Yadav R; Kumar Y; Dahiya D; Bhatia A
    Clin Breast Cancer; 2022 Dec; 22(8):737-752. PubMed ID: 36175290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tight Junction Protein Claudin-12 Is Involved in Cell Migration during Metastasis.
    Kolchakova D; Moten D; Batsalova T; Dzhambazov B
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33922921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudins in Cancer: A Current and Future Therapeutic Target.
    Hana C; Thaw Dar NN; Galo Venegas M; Vulfovich M
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudins in cancer: bench to bedside.
    Osanai M; Takasawa A; Murata M; Sawada N
    Pflugers Arch; 2017 Jan; 469(1):55-67. PubMed ID: 27624415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snail-induced claudin-11 prompts collective migration for tumour progression.
    Li CF; Chen JY; Ho YH; Hsu WH; Wu LC; Lan HY; Hsu DS; Tai SK; Chang YC; Yang MH
    Nat Cell Biol; 2019 Feb; 21(2):251-262. PubMed ID: 30664792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.
    Knezevic J; Pfefferle AD; Petrovic I; Greene SB; Perou CM; Rosen JM
    Oncogene; 2015 Dec; 34(49):5997-6006. PubMed ID: 25746005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
    Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
    Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claudin-4 as therapeutic target in cancer.
    Neesse A; Griesmann H; Gress TM; Michl P
    Arch Biochem Biophys; 2012 Aug; 524(1):64-70. PubMed ID: 22286027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.
    Creighton CJ; Chang JC; Rosen JM
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):253-60. PubMed ID: 20354771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer.
    Kyuno D; Yamaguchi H; Ito T; Kono T; Kimura Y; Imamura M; Konno T; Hirata K; Sawada N; Kojima T
    World J Gastroenterol; 2014 Aug; 20(31):10813-24. PubMed ID: 25152584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Junctions gone bad: claudins and loss of the barrier in cancer.
    Turksen K; Troy TC
    Biochim Biophys Acta; 2011 Aug; 1816(1):73-9. PubMed ID: 21515339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients.
    Gowrikumar S; Primeaux M; Pravoverov K; Wu C; Szeglin BC; Sauvé CG; Thapa I; Bastola D; Chen XS; Smith JJ; Singh AB; Dhawan P
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
    Uthayanan L; El-Bahrawy M
    J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
    Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
    Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dichotomous roles of claudins as tumor promoters or suppressors: lessons from knockout mice.
    Kage H; Flodby P; Zhou B; Borok Z
    Cell Mol Life Sci; 2019 Dec; 76(23):4663-4672. PubMed ID: 31332482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.